Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy | Zendy

Steven A. Yukl | Zendy; Amandeep K. Shergill | Zendy; Kenneth R. McQuaid | Zendy; Sara Gianella | Zendy; Harry Lampiris | Zendy; C. Bradley Hare | Zendy; Mark Pandori | Zendy; Elizabeth Sinclair | Zendy; Huldrych F. Günthard | Zendy; Marek Fischer | Zendy; Joseph K. Wong | Zendy; Diane V. Havlir | Zendy

Open Access

Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy

Author(s) -

Steven A. Yukl,

Amandeep K. Shergill,

Kenneth R. McQuaid,

Sara Gianella,

Harry Lampiris,

C. Bradley Hare,

Mark Pandori,

Elizabeth Sinclair,

Huldrych F. Günthard,

Marek Fischer,

Joseph K. Wong,

Diane V. Havlir

Publication year - 2010

Publication title -

aids

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.195

H-Index - 216

eISSN - 1473-5571

pISSN - 0269-9370

DOI - 10.1097/qad.0b013e32833ef7bb

Subject(s) - raltegravir , ileum , efavirenz , peripheral blood mononuclear cell , immunology , viral load , darunavir , rectum , medicine , gastroenterology , biology , human immunodeficiency virus (hiv) , antiretroviral therapy , biochemistry , in vitro

To determine whether raltegravir-containing antiretroviral therapy (ART) intensification reduces HIV levels in the gut.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research